Literature DB >> 27780637

MiR-106a: Promising biomarker for cancer.

Yao-Jie Pan1, Ying Zhuang2, Jun-Nian Zheng3, Dong-Sheng Pei4.   

Abstract

MicroRNAs (miRNAs), which are characterized by highly conserved and small non-coding RNAs, have been a hot spot regarding biological processes such as cellular proliferation, apoptosis and metabolism as well as cellular differentiation, signal transduction and carcinogenesis. MiRNA-106a (miR-106a), a member of the miR-17 family, has been validated to be aberrantly regulated in the diversity of tumors. The purpose of this review is supposed to deliver an intricate overview of miR-106a, including its role in cell proliferation, apoptosis, cell cycle, invasion and metastasis, involvement in drug resistance as well as its interactions with the target proteins and signaling pathways involved.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; MiR-106a; MicroRNA; Oncogene

Mesh：

Substances：

Year:  2016        PMID： 27780637     DOI： 10.1016/j.bmcl.2016.10.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  14 in total

1.  Up-regulation of miR-106a targets LIMK1 and contributes to cognitive impairment induced by isoflurane anesthesia in mice.

Authors:  Ning Zhang; Weiguang Ye; Tianlong Wang; Hui Wen; Lan Yao
Journal:  Genes Genomics       Date:  2020-01-13       Impact factor: 1.839

2.  LncRNA SNHG16 Aggravates High Glucose-Induced Podocytes Injury in Diabetic Nephropathy Through Targeting miR-106a and Thereby Up-Regulating KLF9.

Authors:  Xin He; Xiuya Zeng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-08       Impact factor: 3.168

3.  NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension.

Authors:  Yunxia Guo; Zhaofang Liu; Ming Wang
Journal:  Cytotechnology       Date:  2021-01-04       Impact factor: 2.058

4.  Physiological response and microRNA expression profiles in head kidney of genetically improved farmed tilapia (GIFT, Oreochromis niloticus) exposed to acute cold stress.

Authors:  Jun Qiang; Yan T Cui; Fan Y Tao; Wen J Bao; Jie He; Xia H Li; Pao Xu; Lan Y Sun
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

5.  Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer.

Authors:  Qiliang Peng; Yi Shen; Kaisu Lin; Li Zou; Yuntian Shen; Yaqun Zhu
Journal:  J Transl Med       Date:  2018-05-15       Impact factor: 5.531

Review 6.  The Network of Non-coding RNAs in Cancer Drug Resistance.

Authors:  Fabio Corrà; Chiara Agnoletto; Linda Minotti; Federica Baldassari; Stefano Volinia
Journal:  Front Oncol       Date:  2018-08-29       Impact factor: 6.244

7.  A feed-forward regulatory network lncPCAT1/miR-106a-5p/E2F5 regulates the osteogenic differentiation of periodontal ligament stem cells.

Authors:  Bo Jia; Xiaoling Qiu; Jun Chen; Xiang Sun; Xianghuai Zheng; Jianjiang Zhao; Qin Li; Zhiping Wang
Journal:  J Cell Physiol       Date:  2019-04-17       Impact factor: 6.384

8.  Long non-coding RNA GASL1 restrains gastric carcinoma cell proliferation and metastasis by sponging microRNA-106a.

Authors:  Dengqiang Liu; Peng Xiao; Chao Feng; Hui Meng; Enxu Bi
Journal:  Cell Cycle       Date:  2020-09-08       Impact factor: 4.534

9.  Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy.

Authors:  Ye Tian; Changyu Sun; Limeng Zhang; Yuan Pan
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

10.  Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.

Authors:  Minghui Li; Yan Zhou; Tiansong Xia; Xin Zhou; Zebo Huang; Huo Zhang; Wei Zhu; Qiang Ding; Shui Wang
Journal:  Breast Cancer Res Treat       Date:  2018-03-20       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.